Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Disc Medicine Inc (IRON)

Disc Medicine Inc (IRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,919,390
  • Shares Outstanding, K 29,758
  • Annual Sales, $ 0 K
  • Annual Income, $ -76,430 K
  • EBIT $ -125 M
  • EBITDA $ -125 M
  • 60-Month Beta 0.76
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.00

Options Overview Details

View History
  • Implied Volatility 59.59% ( -3.44%)
  • Historical Volatility 42.65%
  • IV Percentile 4%
  • IV Rank 2.95%
  • IV High 207.09% on 03/26/24
  • IV Low 55.11% on 05/10/24
  • Put/Call Vol Ratio 0.06
  • Today's Volume 197
  • Volume Avg (30-Day) 59
  • Put/Call OI Ratio 0.70
  • Today's Open Interest 1,594
  • Open Int (30-Day) 1,095

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -1.06
  • Number of Estimates 7
  • High Estimate -0.88
  • Low Estimate -1.41
  • Prior Year -0.97
  • Growth Rate Est. (year over year) -9.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.00 +5.74%
on 12/05/24
68.35 -5.63%
on 12/10/24
+1.95 (+3.12%)
since 11/20/24
3-Month
44.69 +44.33%
on 09/23/24
68.73 -6.15%
on 11/11/24
+16.39 (+34.07%)
since 09/20/24
52-Week
25.60 +151.95%
on 04/01/24
77.60 -16.88%
on 03/04/24
+7.50 (+13.16%)
since 12/20/23

Most Recent Stories

More News
Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

IRON : 64.50 (+2.46%)
Disc Medicine Reports Positive Phase 1b Results for DISC-0974 in Myelofibrosis Anemia and Initiates Phase 2 Study

Disc Medicine's DISC-0974 shows positive hematologic responses in myelofibrosis anemia, leading to a Phase 2 trial initiation.Quiver AI SummaryDisc Medicine, Inc. announced positive results from a Phase...

IRON : 64.50 (+2.46%)
Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting

IRON : 64.50 (+2.46%)
Insider Sale: Director at $IRON (IRON) Sells 173 Shares

William Richard White, a director at $IRON ($IRON), sold 173 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their...

IRON : 64.50 (+2.46%)
Insider Sale: Chief Medical Officer of $IRON (IRON) Sells 1,904 Shares

William Jacob Savage, the Chief Medical Officer of $IRON ($IRON), sold 1,904 shares of the company on 11-25-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...

IRON : 64.50 (+2.46%)
Disc Medicine to Participate in Upcoming Investor Conferences

IRON : 64.50 (+2.46%)
Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update

IRON : 64.50 (+2.46%)
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.

IRON : 64.50 (+2.46%)
Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

IRON : 64.50 (+2.46%)
Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval

IRON : 64.50 (+2.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Disc Medicine Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases. Disc Medicine Inc., formerly known as Gemini Therapeutics Inc., is based in WAYLAND, Mass.

See More

Key Turning Points

3rd Resistance Point 70.14
2nd Resistance Point 67.64
1st Resistance Point 66.07
Last Price 64.50
1st Support Level 62.00
2nd Support Level 59.50
3rd Support Level 57.93

See More

52-Week High 77.60
Last Price 64.50
Fibonacci 61.8% 57.74
Fibonacci 50% 51.60
Fibonacci 38.2% 45.46
52-Week Low 25.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar